Overview
Sumio Ohtsuki practices in Japan. Mr. Ohtsuki is rated as an Advanced expert by MediFind in the treatment of X-Linked Creatine Deficiency. His top areas of expertise are X-Linked Creatine Deficiency, Brain Tumor, Glioblastoma, and Astrocytoma.
His clinical research consists of co-authoring 144 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of X-Linked Creatine Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- X-Linked Creatine DeficiencyMr. Ohtsuki isAdvanced. Learn about X-Linked Creatine Deficiency.
- Experienced
- Alport SyndromeMr. Ohtsuki isExperienced. Learn about Alport Syndrome.
- Alzheimer's DiseaseMr. Ohtsuki isExperienced. Learn about Alzheimer's Disease.
- AstrocytomaMr. Ohtsuki isExperienced. Learn about Astrocytoma.
- Brain TumorMr. Ohtsuki isExperienced. Learn about Brain Tumor.
- Cerebral Ventricle CancerMr. Ohtsuki isExperienced. Learn about Cerebral Ventricle Cancer.
- Choroid Plexus CarcinomaMr. Ohtsuki isExperienced. Learn about Choroid Plexus Carcinoma.